These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design. Rudolph B; Bjorklund N; Ovchinsky N; Kogan-Liberman D; Perez A; Liszewski M; Levin TL; Ewart M; Liu Q; Xue X; Viswanathan S; Strickler HD Contemp Clin Trials; 2018 Dec; 75():51-58. PubMed ID: 30401631 [TBL] [Abstract][Full Text] [Related]
51. Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis. Rosenblatt R; Mehta A; Snell D; Hissong E; Kierans AS; Kumar S Dig Dis Sci; 2019 Jan; 64(1):262-268. PubMed ID: 30269271 [TBL] [Abstract][Full Text] [Related]
52. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease. Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954 [TBL] [Abstract][Full Text] [Related]
53. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. Patton HM; Yates K; Unalp-Arida A; Behling CA; Huang TT; Rosenthal P; Sanyal AJ; Schwimmer JB; Lavine JE Am J Gastroenterol; 2010 Sep; 105(9):2093-102. PubMed ID: 20372110 [TBL] [Abstract][Full Text] [Related]
54. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310 [TBL] [Abstract][Full Text] [Related]
55. The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease. Petta S; Tuttolomondo A; Gagliardo C; Zafonte R; Brancatelli G; Cabibi D; Cammà C; Di Marco V; Galvano L; La Tona G; Licata A; Magliozzo F; Maida C; Marchesini G; Merlino G; Midiri M; Parrinello G; Torres D; Pinto A; Craxì A Medicine (Baltimore); 2016 Apr; 95(16):e3446. PubMed ID: 27100443 [TBL] [Abstract][Full Text] [Related]
56. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data. Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177 [TBL] [Abstract][Full Text] [Related]
57. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD. Polyzos SA; Perakakis N; Boutari C; Kountouras J; Ghaly W; Anastasilakis AD; Karagiannis A; Mantzoros CS J Clin Endocrinol Metab; 2020 Mar; 105(3):e390-400. PubMed ID: 31690932 [TBL] [Abstract][Full Text] [Related]
59. The common marmoset as a model for the study of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Kramer JA; Grindley J; Crowell AM; Makaron L; Kohli R; Kirby M; Mansfield KG; Wachtman LM Vet Pathol; 2015 Mar; 52(2):404-13. PubMed ID: 24913270 [TBL] [Abstract][Full Text] [Related]